Blog
Zoloft® Birth Defects Lawyer & Lawsuit
The SSRI antidepressant drug Zoloft® has been found to increase the risk of life-threatening birth defects in infants. Zoloft Lawsuit Update: On July 4, 2011, a study published in the Archives of General Psychiatry announced that children born to mothers who took an SSRI antidepressant like Zoloft during pregnancy may have an increased risk…
Public Citizen Lobbying For Increased FDA Regulation With Generic Drugs
Public Citizen, a consumer organization consisting of more than 225,000 members and supporters nationwide, has acted as the people’s voice in the capitol since 1971. By actively supporting public interest, the organization has successfully challenged corrupt practices in the pharmaceutical, nuclear and automobile industries. Continuing with their efforts, Public Citizen has recently submitted a…
Prominent Medical Device Manufacturer Announces the Discontinuation of Several Transvaginal Mesh Devices
Recent years have witnessed the surgical application of transvaginal mesh devices become a subject of great concern in the healthcare community. The use of these devices has become synonymous with the development of severe, life-threatening complications. As a result, recipients experiencing mesh failure have frequently sought compensation for their pain and suffering by filing…
Defective Hip Replacement Systems May Be Responsible For an Increase In Serum Metal Ion Levels
The adverse effects associated with metal-on-metal hip replacement systems has become a significant concern in the healthcare community. The potentially hazardous side effects of elevated systemic exposure to cobalt, chromium and molybdenum are of significant concern, especially following metal-on-metal hip resurfacing, standard total hip arthroplasty or any other joint replacement system involving metal components….
FDA Questions Give Insight To The Future Of Transvaginal Mesh Products
September 8-9, 2011 will witness an advisory committee of the U.S. Food and Drug Administration (FDA) convene to discuss the future of transvaginal mesh products. The Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee hopes to present the FDA with substantial evidence pertaining to the use of transvaginal mesh. However, the…
Abnormal Heart Rhythms Associated With High Doses of Celexa
Healthcare officials at the U.S. Food and Drug Administration (FDA) have recently acknowledged new dangers associated with one of the world’s most popular antidepressants. Recent studies suggest that Celexa (citalopram hydrobromide), a selective serotonin reuptake inhibitor (SSRI), may be responsible for patients developing abnormal electrical activity in their heart. Doses larger than 40 mg…
Roster Set For Upcoming Transvaginal Mesh Advisory Committee
An influx of adverse transvaginal mesh reports have become the subject of intense scrutiny in the healthcare community. The past two years have witnessed an exponential growth in complications associated with the surgical application of transvaginal mesh products. Due to the frequency and severity in which these adverse events are being reported, a public…
Cook Biotech Inc. Urges The FDA To Consider New Information When Deliberating Vaginal Mesh Recommendations
In response to the upcoming advisory committee, scheduled to meet on September 8-9, Cook Biotech Incorporated has submitted information to be considered by the U.S. Food and Drug Administration (FDA) regarding the safety and effectiveness of transvaginal mesh products used in the treatment of pelvic organ prolapse (POP). An influx of adverse transvaginal mesh…